Home | Structured Search | Drug Resource
Find: within
Malaria > Non-drug Therapy Author: Rick M. Fairhurst, MD, PhD; Thomas E. Wellems, MD, PhD
Module updated - 2009-11-19
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • High parasitemia has been correlated with mortality in P. falciparum malaria.
  • Despite appropriate medical treatment, mortality in patients with >10% parasitemia ranges from 20% to 40% when cerebral or renal function is impaired, and up to 80% in the presence of acute respiratory distress syndrome.
  • Exchange transfusion may reduce parasite load, remove toxic substances, reduce microcirculatory sludging, and rapidly correct anemia.

Evidence:

  • Several case reports and a small case series have described successful exchange transfusion in patients with severe malaria (96; 97; 98).
  • Retrospective studies that compared severe malaria cases treated with adjunct exchange transfusion with patients receiving chemotherapy alone have been limited by small numbers of cases and noncomparability of study groups (99; 100).
  • One prospective study in Zimbabwe compared survival of eight severe malaria cases randomly assigned to receive either chemotherapy alone or chemotherapy with exchange transfusion. Whereas three out of four patients receiving chemotherapy alone died, all four patients receiving exchange transfusion as adjunct therapy survived. Due to the small number of patients, a statistically significant benefit of exchange transfusion could not be demonstrated (101).
  • A recent meta-analysis of eight case-control studies concluded that exchange transfusion was not associated with a higher survival rate than was antimalarial chemotherapy alone (102).
  • A case series of six patients showed reductions in parasitemia from 23% to 80% to 13% to 20% following exchange transfusion (103).

Comments:

  • In these studies, there were problems with comparability of case and control groups: patients who had exchange transfusion had higher parasitemia and more severe malaria. Furthermore, survival rates were higher among patients with partial immunity when compared with patients with no immunity. No iatrogenic deaths were described in these studies. No sufficiently powered, randomized, controlled study has been reported to date.
  • The World Health Organization guidelines for exchange transfusion have been published (55).
  • Partial exchange transfusion has been successfully performed in young children (104).

FAQs
Harry Tagbor, MBChB, DrPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Rick M. Fairhurst, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Thomas E. Wellems, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.